San Francisco, United States
Omniox Inc, founded in 2006, is a pioneering entity in the biotechnology field, dedicated to innovating solutions for critical health issues like cancer and cardiovascular diseases. Their slogan, "Omniox, a biotechnology company, commercializes technologies used in identifying and treating cancer, cardiovascular disease and trauma," encapsulates their mission.
The company has carved a niche in developing biotherapeutics targeting ischemic, hypoxic, and anemic diseases, prevalent in oncology, cardiovascular diseases, and trauma care. By addressing prior biochemical limitations in oxygen and nitric oxide delivery, Omniox Inc sets a new standard for effective medical treatments.
Headquartered in the United States, Omniox Inc recently secured a Venture Round investment on 01 November 2023, with backing from prominent investors like Samsara BioCapital, Wavemaker 360, and Acadia Woods Partners. This funding supports their continued R&D, promising substantial returns in the burgeoning Health Care and Health and Wellness sectors.
